Interstitial lung disease and sleep: What is known?

Shikhar Agarwal, Brittany Richardson, Vidya Krishnan, Hartmut Schneider, Nancy A. Collop, Sonye Danoff

Research output: Contribution to journalArticle

Abstract

Objectives: Pulmonary fibrosis (PF), a group of disorders characterized by progressive scarring of the lung parenchyma, affects over 500,000 Americans. Fatigue is a common and frequently disabling symptom in PF. We have previously described poor subjective sleep quality in this patient population. We sought to ascertain what is known regarding sleep in PF. Methods: We reviewed the English language literature for reports on sleep and sleep disorders in patients with PF. Results: The existing literature is small and heterogeneous with regard to inclusion criteria. There are a number of distinctive changes in sleep architecture associated with PF including decreased REM sleep and increased sleep fragmentation. In addition, there is suggestion of possible sleep disturbances in this population including OSA, although the frequency of such sleep abnormalities as well as predictors of these abnormalities remain uncertain. Conclusions: There is significant need for larger studies characterizing sleep in patients with defined PF. These studies are particularly critical given the limited options for therapy in patients with PF and the impact of fatigue in this disorder.

Original languageEnglish (US)
Pages (from-to)947-951
Number of pages5
JournalSleep Medicine
Volume10
Issue number9
DOIs
StatePublished - Oct 2009

Fingerprint

Pulmonary Fibrosis
Interstitial Lung Diseases
Sleep
Fatigue
Sleep Deprivation
REM Sleep
Population
Cicatrix
Language
Lung

Keywords

  • Fatigue
  • Idiopathic pulmonary fibrosis
  • Nocturnal oxygen desaturation
  • Obstructive sleep apnea
  • Sleep architecture
  • Sleep quality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Agarwal, S., Richardson, B., Krishnan, V., Schneider, H., Collop, N. A., & Danoff, S. (2009). Interstitial lung disease and sleep: What is known? Sleep Medicine, 10(9), 947-951. https://doi.org/10.1016/j.sleep.2009.01.004

Interstitial lung disease and sleep : What is known? / Agarwal, Shikhar; Richardson, Brittany; Krishnan, Vidya; Schneider, Hartmut; Collop, Nancy A.; Danoff, Sonye.

In: Sleep Medicine, Vol. 10, No. 9, 10.2009, p. 947-951.

Research output: Contribution to journalArticle

Agarwal, S, Richardson, B, Krishnan, V, Schneider, H, Collop, NA & Danoff, S 2009, 'Interstitial lung disease and sleep: What is known?', Sleep Medicine, vol. 10, no. 9, pp. 947-951. https://doi.org/10.1016/j.sleep.2009.01.004
Agarwal S, Richardson B, Krishnan V, Schneider H, Collop NA, Danoff S. Interstitial lung disease and sleep: What is known? Sleep Medicine. 2009 Oct;10(9):947-951. https://doi.org/10.1016/j.sleep.2009.01.004
Agarwal, Shikhar ; Richardson, Brittany ; Krishnan, Vidya ; Schneider, Hartmut ; Collop, Nancy A. ; Danoff, Sonye. / Interstitial lung disease and sleep : What is known?. In: Sleep Medicine. 2009 ; Vol. 10, No. 9. pp. 947-951.
@article{0858bea358fe42d9baeb39d1bccec85e,
title = "Interstitial lung disease and sleep: What is known?",
abstract = "Objectives: Pulmonary fibrosis (PF), a group of disorders characterized by progressive scarring of the lung parenchyma, affects over 500,000 Americans. Fatigue is a common and frequently disabling symptom in PF. We have previously described poor subjective sleep quality in this patient population. We sought to ascertain what is known regarding sleep in PF. Methods: We reviewed the English language literature for reports on sleep and sleep disorders in patients with PF. Results: The existing literature is small and heterogeneous with regard to inclusion criteria. There are a number of distinctive changes in sleep architecture associated with PF including decreased REM sleep and increased sleep fragmentation. In addition, there is suggestion of possible sleep disturbances in this population including OSA, although the frequency of such sleep abnormalities as well as predictors of these abnormalities remain uncertain. Conclusions: There is significant need for larger studies characterizing sleep in patients with defined PF. These studies are particularly critical given the limited options for therapy in patients with PF and the impact of fatigue in this disorder.",
keywords = "Fatigue, Idiopathic pulmonary fibrosis, Nocturnal oxygen desaturation, Obstructive sleep apnea, Sleep architecture, Sleep quality",
author = "Shikhar Agarwal and Brittany Richardson and Vidya Krishnan and Hartmut Schneider and Collop, {Nancy A.} and Sonye Danoff",
year = "2009",
month = "10",
doi = "10.1016/j.sleep.2009.01.004",
language = "English (US)",
volume = "10",
pages = "947--951",
journal = "Sleep Medicine",
issn = "1389-9457",
publisher = "Elsevier",
number = "9",

}

TY - JOUR

T1 - Interstitial lung disease and sleep

T2 - What is known?

AU - Agarwal, Shikhar

AU - Richardson, Brittany

AU - Krishnan, Vidya

AU - Schneider, Hartmut

AU - Collop, Nancy A.

AU - Danoff, Sonye

PY - 2009/10

Y1 - 2009/10

N2 - Objectives: Pulmonary fibrosis (PF), a group of disorders characterized by progressive scarring of the lung parenchyma, affects over 500,000 Americans. Fatigue is a common and frequently disabling symptom in PF. We have previously described poor subjective sleep quality in this patient population. We sought to ascertain what is known regarding sleep in PF. Methods: We reviewed the English language literature for reports on sleep and sleep disorders in patients with PF. Results: The existing literature is small and heterogeneous with regard to inclusion criteria. There are a number of distinctive changes in sleep architecture associated with PF including decreased REM sleep and increased sleep fragmentation. In addition, there is suggestion of possible sleep disturbances in this population including OSA, although the frequency of such sleep abnormalities as well as predictors of these abnormalities remain uncertain. Conclusions: There is significant need for larger studies characterizing sleep in patients with defined PF. These studies are particularly critical given the limited options for therapy in patients with PF and the impact of fatigue in this disorder.

AB - Objectives: Pulmonary fibrosis (PF), a group of disorders characterized by progressive scarring of the lung parenchyma, affects over 500,000 Americans. Fatigue is a common and frequently disabling symptom in PF. We have previously described poor subjective sleep quality in this patient population. We sought to ascertain what is known regarding sleep in PF. Methods: We reviewed the English language literature for reports on sleep and sleep disorders in patients with PF. Results: The existing literature is small and heterogeneous with regard to inclusion criteria. There are a number of distinctive changes in sleep architecture associated with PF including decreased REM sleep and increased sleep fragmentation. In addition, there is suggestion of possible sleep disturbances in this population including OSA, although the frequency of such sleep abnormalities as well as predictors of these abnormalities remain uncertain. Conclusions: There is significant need for larger studies characterizing sleep in patients with defined PF. These studies are particularly critical given the limited options for therapy in patients with PF and the impact of fatigue in this disorder.

KW - Fatigue

KW - Idiopathic pulmonary fibrosis

KW - Nocturnal oxygen desaturation

KW - Obstructive sleep apnea

KW - Sleep architecture

KW - Sleep quality

UR - http://www.scopus.com/inward/record.url?scp=69949143569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69949143569&partnerID=8YFLogxK

U2 - 10.1016/j.sleep.2009.01.004

DO - 10.1016/j.sleep.2009.01.004

M3 - Article

C2 - 19272836

AN - SCOPUS:69949143569

VL - 10

SP - 947

EP - 951

JO - Sleep Medicine

JF - Sleep Medicine

SN - 1389-9457

IS - 9

ER -